EA201400828A1 - Фармацевтическая композиция в качестве субстанции антирефлюксного антацидного препарата - Google Patents
Фармацевтическая композиция в качестве субстанции антирефлюксного антацидного препаратаInfo
- Publication number
- EA201400828A1 EA201400828A1 EA201400828A EA201400828A EA201400828A1 EA 201400828 A1 EA201400828 A1 EA 201400828A1 EA 201400828 A EA201400828 A EA 201400828A EA 201400828 A EA201400828 A EA 201400828A EA 201400828 A1 EA201400828 A1 EA 201400828A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- pharmaceutical composition
- antireflux
- substance
- antacid preparation
- antacid
- Prior art date
Links
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical class [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 title abstract 3
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 229940069428 antacid Drugs 0.000 title 1
- 239000003159 antacid agent Substances 0.000 title 1
- 230000001458 anti-acid effect Effects 0.000 title 1
- 230000000151 anti-reflux effect Effects 0.000 title 1
- 239000000126 substance Substances 0.000 title 1
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 229910000019 calcium carbonate Inorganic materials 0.000 abstract 1
- 235000010216 calcium carbonate Nutrition 0.000 abstract 1
- 230000001419 dependent effect Effects 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 210000001035 gastrointestinal tract Anatomy 0.000 abstract 1
- 229910052588 hydroxylapatite Inorganic materials 0.000 abstract 1
- 150000002681 magnesium compounds Chemical class 0.000 abstract 1
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 abstract 1
- 235000015497 potassium bicarbonate Nutrition 0.000 abstract 1
- 229910000028 potassium bicarbonate Inorganic materials 0.000 abstract 1
- 239000011736 potassium bicarbonate Substances 0.000 abstract 1
- TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical compound [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 abstract 1
- 235000010413 sodium alginate Nutrition 0.000 abstract 1
- 229940005550 sodium alginate Drugs 0.000 abstract 1
- 239000000661 sodium alginate Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
- A61K33/10—Carbonates; Bicarbonates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/734—Alginic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Фармацевтическая композиция, содержащая альгинат натрия, карбонат кальция, бикарбонат калия, магнийсодержащее соединение и гидроксиапатит, для лечения кислотозависимых заболеваний желудочно-кишечного тракта.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| BY20120125 | 2012-01-27 | ||
| PCT/IB2013/050602 WO2013111077A1 (en) | 2012-01-27 | 2013-01-24 | Pharmaceutical composition as a substance for antireflux antacid drug |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| EA201400828A1 true EA201400828A1 (ru) | 2014-11-28 |
| EA025430B1 EA025430B1 (ru) | 2016-12-30 |
Family
ID=47844411
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EA201400828A EA025430B1 (ru) | 2012-01-27 | 2013-01-24 | Фармацевтическая композиция в качестве субстанции антирефлюксного антацидного препарата |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP2806880B2 (ru) |
| EA (1) | EA025430B1 (ru) |
| LT (1) | LT2806880T (ru) |
| PL (1) | PL2806880T5 (ru) |
| WO (1) | WO2013111077A1 (ru) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2684437B1 (es) * | 2017-03-29 | 2019-08-22 | De Vicente Manuel Mateos | Formulación farmacéutica y su uso para preparar un medicamento para el tratamiento de la acidez |
| FR3101773B1 (fr) | 2019-10-10 | 2023-04-21 | Regeska | Procede de mineralisation d’une membrane de biopolymere |
| CN111388436A (zh) * | 2020-04-20 | 2020-07-10 | 北京健讯医药科技有限公司 | 一种海藻酸钠咀嚼片及其制备方法 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1199039A (en) * | 1966-11-21 | 1970-07-15 | Richardson Merrell Inc | Antacid Composition |
| GB1524740A (en) | 1976-11-09 | 1978-09-13 | Reckitt & Colmann Prod Ltd | Pharmaceutical compositions for use in the suppression of gastric reflux |
| US4414198A (en) | 1982-04-23 | 1983-11-08 | Joseph Michaelson | Rapidly disintegrable tablet composition and method |
| US4869902A (en) | 1984-04-19 | 1989-09-26 | Rorer Pharmaceutical Corporation | Antacid composition |
| JPH0764737B2 (ja) | 1984-04-19 | 1995-07-12 | ローヌ−プーラン ローラー インターナショナル (ホウルディングス) インコーポレイテッド | 制酸組成物 |
| EP0250572A1 (en) | 1986-01-03 | 1988-01-07 | The University Of Melbourne | Gastro-oesophageal reflux composition |
| US4744986A (en) | 1986-03-07 | 1988-05-17 | Rorer Pharmaceutical Corporation | Process for the preparation of a viscosity-stable antacid composition |
| US5112813A (en) | 1986-03-07 | 1992-05-12 | Rhone-Poulenc Rorer Pharmaceuticals Inc. | Process for the preparation of a viscosity-stable antacid composition |
| GB9504599D0 (en) * | 1995-03-03 | 1995-04-26 | Reckitt & Colmann Prod Ltd | Improvements in or relating to organic compositions |
| GB2384986B (en) * | 2002-02-12 | 2004-01-07 | Reckitt Benckiser Healthcare | Compositions for the treatment of disorders of the upper gastrointestinal tract |
-
2013
- 2013-01-24 PL PL13708527T patent/PL2806880T5/pl unknown
- 2013-01-24 EA EA201400828A patent/EA025430B1/ru not_active IP Right Cessation
- 2013-01-24 LT LTEP13708527.0T patent/LT2806880T/lt unknown
- 2013-01-24 EP EP13708527.0A patent/EP2806880B2/en not_active Not-in-force
- 2013-01-24 WO PCT/IB2013/050602 patent/WO2013111077A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| EP2806880B2 (en) | 2020-04-22 |
| EP2806880B1 (en) | 2017-05-03 |
| PL2806880T3 (pl) | 2017-10-31 |
| PL2806880T5 (pl) | 2020-09-07 |
| WO2013111077A1 (en) | 2013-08-01 |
| LT2806880T (lt) | 2017-08-25 |
| EP2806880A1 (en) | 2014-12-03 |
| EA025430B1 (ru) | 2016-12-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA201200551A1 (ru) | Фармацевтическая композиция, фармацевтическая дозированная форма, способы их получения и применения для лечения | |
| EA201300323A1 (ru) | Материалы и способы улучшения функции желудочно-кишечного тракта | |
| WO2011161056A3 (en) | Dialysis precursor composition | |
| EA201300053A1 (ru) | Фосфатсвязывающий препарат для удобного приема | |
| EA201291336A1 (ru) | Замещенные 5-фтор-1н-пиразолопиридины и их применение | |
| EA201270741A1 (ru) | Пероральные композиции и липофильные соли метилналтрексона | |
| EA201491009A1 (ru) | Гель лизата тромбоцитов | |
| EA201300146A1 (ru) | ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ МОДУЛЯТОРА c-МЕТ | |
| HK1209029A1 (en) | Zirconium silicate for treatment of hyperkalemia | |
| CY1118813T1 (el) | Φαρμακευτικες συνθεσεις συν-κρυσταλλων τραμαδολης και κοξιμπων | |
| EA033374B1 (ru) | Твердые фармацевтические композиции, содержащие энзалутамид, и способ лечения | |
| EA201300989A1 (ru) | Водная фармацевтическая композиция тапентадола для перорального введения | |
| UA110612C2 (ru) | Производные 1-амино-2-циклопропилетилбороновои кислоты | |
| EA200970581A1 (ru) | Кристаллическое твёрдое основание разагилина | |
| EA201591166A1 (ru) | Ингибиторы аутотаксина | |
| EA201100153A1 (ru) | Никотинсодержащие мягкие желатиновые пастилки | |
| EA201171399A1 (ru) | Способ и композиция для улучшения всасывания лекарственных средств | |
| EA201291211A1 (ru) | Фармацевтические композиции, содержащие гидроморфон и налоксон | |
| EA201200616A1 (ru) | Производные 2-оксо-1-пирролидинилимидазотиадиазола | |
| PH12012502082A1 (en) | Combination of active loaded granules with additional actives | |
| WO2010056527A3 (en) | B-biphenyl sulfonamide compounds as ion channel modulators | |
| EA201291022A1 (ru) | Твердая фармацевтическая композиция для нейтрализации желудочной кислоты | |
| EA201100287A1 (ru) | Композиция ропинирола | |
| EA201400828A1 (ru) | Фармацевтическая композиция в качестве субстанции антирефлюксного антацидного препарата | |
| EA201390117A1 (ru) | Композиция антител к vegfr-3 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM4A | Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s) |
Designated state(s): AM AZ KG TJ TM |